Md S. Hossain
Fukuoka, 8112501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies.
Journal: Cancers
Published: February 17, 2026
KIT-13, a novel plasmalogen derivative, attenuates neuroinflammation and amplifies cognition.
Journal: Frontiers in cell and developmental biology
Published: June 04, 2024
New Approach as Inhibitor Against Head-Neck Cancer by In silico, DFT, FMOs, Docking, Molecular Dynamic, and ADMET of Euphorbia tirucalli (Pencil Cactus).
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: March 10, 2024
Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen-Based Nanomedicines.
Journal: Advanced healthcare materials
Published: December 25, 2023
Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies.
Journal: Communications chemistry
Published: June 22, 2023
MonkeyNet: A robust deep convolutional neural network for monkeypox disease detection and classification.
Journal: Neural networks : the official journal of the International Neural Network Society
Published: July 23, 2022
Plasmalogens inhibit neuroinflammation and promote cognitive function.
Journal: Brain research bulletin
Published: June 27, 2022
Plasmalogen-Mediated Activation of GPCR21 Regulates Cytolytic Activity of NK Cells against the Target Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 09, 2022
Plasmalogens, the Vinyl Ether-Linked Glycerophospholipids, Enhance Learning and Memory by Regulating Brain-Derived Neurotrophic Factor.
Journal: Frontiers in cell and developmental biology
Published: December 03, 2021
Plasmalogens ensure the stability of non-neuronal (microglial) cells during long-term cytotoxicity.
Journal: Environmental science and pollution research international
Published: June 18, 2021
NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers.
Journal: Frontiers in oncology
Published: February 19, 2021
Last Updated: 09/26/2026